Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters
Database
Language
Document Type
Year range
1.
Impact of direct-acting antiviral use for chronic hepatitis C on health care costs in Medicaid: economic model update.
Roebuck, M Christopher.
Am J Manag Care ; 28(12): 630-631, 2022 12.
Article in English | MEDLINE | ID: covidwho-2206468

ABSTRACT

Curative direct-acting antivirals for chronic hepatitis C provide a net economic benefit to Medicaid in less than 1 year. Cumulative savings to date have exceeded $15 billion.


Subject(s)
Hepatitis C, Chronic , Hepatitis C , United States , Humans , Hepatitis C, Chronic/drug therapy , Antiviral Agents/therapeutic use , Medicaid , Health Care Costs , Models, Economic
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL